MTX depletes intracellular reduced folate by inhibiting thymidylate synthase and dihydrofolate reductase (DHFR), disrupting DNA and RNA synthesis and leading to cell death, particularly in high‐turnover tissues like the oral mucosa, resulting in oral mucositis [6, 7]. Here, DHFR is linked to oral mucositis.